Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
Uveitis is a rare adverse event of dupilumab, that typically affects both eyes and often leads to discontinuation of therapy. In this article, we report a case of a 28-year-old female with atopic dermatitis who developed new-onset iridocyclitis, a form of uveitis, in her left eye 2 weeks after start...
Main Authors: | Shiyu Zhang, Lu Lu, Jindi Feng, Zhonghui Hu, Hongbin Song, Lu Yang, Yuehua Liu, Di Chen, Tao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2023.2229466 |
Similar Items
-
Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
by: Federica Gelato, et al.
Published: (2023-03-01) -
Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
by: Jowita Sroka-Tomaszewska, et al.
Published: (2024-01-01) -
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
by: T. Torres, et al.
Published: (2022-07-01) -
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01) -
Conjunctivitis as a common adverse effect of dupilumab
in atopic dermatitis
by: Mikołaj Cichoń, et al.
Published: (2023-03-01)